Showing posts with label drugs. Show all posts
Showing posts with label drugs. Show all posts

Friday, March 18, 2016

Answers to Your Top Questions on Substance Use Disorders

"Michael Botticelli answers questions from a Facebook chat with The Addict's Mom, an online community of loved ones of those struggling with substance use disorders.

A few weeks ago, I joined in a Facebook chat with The Addict's Mom, an online community of mothers with children and family members suffering from substance use disorders. It was a privilege for me to listen to their experiences and help provide answers on the heroin and prescription opioid epidemic in this country.
I couldn't respond to all of the questions asked in the chat, but as promised, my team and I put together answers for some of the most-asked questions. Take a look, and share if you know any friends or family who might have similar questions.."
Substance abuse

Saturday, January 9, 2016

Drug Overdode Deaths by State: 2013 and 2014

"CDC analyzed recent multiple cause-of-death mortality data from the National Vital Statistics System to track current trends and shifting characteristics of drug overdose deaths. Opioids—primarily prescription pain relievers and heroin—are the main driver of overdose deaths. Opioids were involved in 28,647 deaths in 2014 and opioid overdoses have quadrupled since 2000.
Significant increases in drug overdose death rates were seen in the Northeast, Midwest and South  Census Regions. In 2014, the five states with the highest rates of death due to drug overdose were West Virginia, New Mexico, New Hampshire, Kentucky and Ohio. States with statistically significant increases in the rate from 2013 to 2014 included Alabama, Georgia, Illinois, Indiana, Maine, Maryland, Massachusetts, Michigan, New Hampshire, New Mexico, North Dakota, Ohio, Pennsylvania and Virginia..."
Drug overdose

Monday, December 28, 2015

Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014

"The United States is experiencing an epidemic of drug overdose (poisoning) deaths. Since 2000, the rate of deaths from drug overdoses has increased 137%, including a 200% increase in the rate of overdose deaths involving opioids (opioid pain relievers and heroin). CDC analyzed recent multiple cause-of-death mortality data to examine current trends and characteristics of drug overdose deaths, including the types of opioids associated with drug overdose deaths. During 2014, a total of 47,055 drug overdose deaths occurred in the United States, representing a 1-year increase of 6.5%, from 13.8 per 100,000 persons in 2013 to 14.7 per 100,000 persons in 2014. The rate of drug overdose deaths increased significantly for both sexes, persons aged 25–44 years and ≥55 years, non-Hispanic whites and non-Hispanic blacks, and in the Northeastern, Midwestern, and Southern regions of the United States. Rates of opioid overdose deaths also increased significantly, from 7.9 per 100,000 in 2013 to 9.0 per 100,000 in 2014, a 14% increase. Historically, CDC has programmatically characterized all opioid pain reliever deaths (natural and semisynthetic opioids, methadone, and other synthetic opioids) as "prescription" opioid overdoses (1). Between 2013 and 2014, the age-adjusted rate of death involving methadone remained unchanged; however, the age-adjusted rate of death involving natural and semisynthetic opioid pain relievers, heroin, and synthetic opioids, other than methadone (e.g., fentanyl) increased 9%, 26%, and 80%, respectively. The sharp increase in deaths involving synthetic opioids, other than methadone, in 2014 coincided with law enforcement reports of increased availability of illicitly manufactured fentanyl, a synthetic opioid; however, illicitly manufactured fentanyl cannot be distinguished from prescription fentanyl in death certificate data. These findings indicate that the opioid overdose epidemic is worsening. There is a need for continued action to prevent opioid abuse, dependence, and death, improve treatment capacity for opioid use disorders, and reduce the supply of illicit opioids, particularly heroin and illicit fentanyl..."
Overdose deaths

Monday, November 16, 2015

Drug Offenders in Federal Prison: Estimates of Characteristics Based on Linked Data

"Publicly available BOP datasets do not include information about prisoners’ criminal history, offense details, and sentencing decisions, making it difficult to assess the criminal background of the offenders and the nature of their offenses. This report uses a new dataset that links the BOP population at fiscal yearend 2012 (i.e., stock population), with sentencing information from the U.S. Sentencing Commission (USSC) to describe the federal prison population in greater detail. The dataset includes the 94,678 sentenced offenders in federal prison whose most serious offense was drug-related, who were serving time on a new U.S. district court commitment, and who had valid links to USSC data. Of these, almost all were drug trafficking offenders, while the remainder were sentenced for other drug offenses, primarily possession..."
Drug offenders

Sunday, August 9, 2015

FDA Guidance Documents

"The table below lists all official FDA Guidance Documents and other regulatory guidance. You can search for documents using key words, and you can narrow or filter your results by product, date issued, FDA organizational unit, type of document, subject, draft or final status, and comment period.
This feature is provided to give a convenient way to search for all FDA guidance documents from a single location. We will continue to refine it as we observe its performance.
If you cannot find the document you’re looking for here, you can browse separate collections of guidance documents by topic.,,:
FDA

Friday, September 26, 2014

National Prescription Drug Take-Back Day

 "September 27, 2014. 10AM to 2PM
The National Prescription Drug Take-Back Day aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse of medications..."
Locate a site near you.
Prescription drug returns

Saturday, September 20, 2014

Report to the President on Combating Antibiotic Resistance

"This report offers practical recommendations to the Federal government for strengthening the
Nation’s ability to combat the rise in antibiotic ‐resistant bacteria. PCAST finds
that without rapid and coordinated action, the Nation risks losing the tremendous
public health progress made over the last century from the discovery and development of antibiotic drugs, thereby threatening patient care, economic growth, public health, agriculture, economic security, and national security.."

Antibiotic_resistance

Thursday, July 17, 2014

2014 National Drug Control Strategy

"I am pleased to transmit the 2014 National Drug Control Strategy , a 21st century approach to drug policy that is built on decades of research demonstrating that addiction is a disease of the brain—one that can be prevented, treated, and from which people can recover. The pages that follow lay out an evidence-based plan
for real drug policy reform, spanning the spectrum of effective prevention, early intervention, treatment, recovery support, criminal justice, law enforcement, and international cooperation.."
National Drug Policy

Tuesday, April 8, 2014

Counterfeit Drugs

"The World Health Organization recently issued an alert [PDF - 652KB]External Web Site Icon about counterfeit antimalarial medications being sold in West and Central Africa. Travelers should be aware that drugs purchased in other countries may be counterfeit.

Counterfeit (or fake) medicines are manufactured using incorrect or harmful ingredients. These medicines are then packaged and labeled to look like real brand-name and generic drugs. Counterfeit medicines are unsafe because they may not be effective or may even harm you..."
Counterfeit Drugs

Friday, September 28, 2012

Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings

"This report presents a first look at results from the 2011 National Survey on Drug Use and Health (NSDUH), an annual survey of the civilian, noninstitutionalized population of the United States aged 12 years old or older. The report presents national estimates of rates of use, numbers of users, and other measures related to illicit drugs, alcohol, and tobacco products. The report focuses on trends between 2010 and 2011 and from 2002 to 2011, as well as differences across population subgroups in 2011. NSDUH estimates related to mental health, which were included in national findings reports prior to 2009, are not included in this 2011 report..."
http://www.samhsa.gov/data/NSDUH/2k11Results/NSDUHresults2011.pdf

Monday, August 6, 2012

Pet Medications Workshop

"The Federal Trade Commission will host a one-day public workshop on October 2, 2012, to examine competition and consumer protection issues in the pet medications industry.  The quality and cost of pet medications is an important pocketbook issue for many consumers.  In 2011, 62 percent of U.S. households owned a pet, and Americans spent an estimated $50 billion on their pets, including nearly $7 billion for prescription and over-the-counter pet medications..." 

Wednesday, May 23, 2012

Depression: Medicines for You

"Use this guide to help you talk to your doctor, pharmacist, or nurse about your medicines for depression. The guide lists all of the FDA-approved products now available to treat this condition. You will also find some general information to help you use your medicines wisely..."

Wednesday, March 7, 2012

FDA Voice

Keep up with activities of the Food and Drug Administration with the its new blog, g FDA Voice.

Tuesday, August 30, 2011

Your Guide to Reporting Problems to FDA
"Consumers play an important public health role by reporting to the Food and Drug Administration (FDA) any adverse events (unexpected side effects) after using a medical product, or other problems with any products that the agency regulates. Timely reporting allows the agency to take prompt action. There are a number of ways you can report problems to the agency, depending on the type of problem and product. The following tips and chart will help you make your report..."

Saturday, May 28, 2011

Potential Effects of a Ban on Direct-to-Consumer Advertising of New Prescription Drug
"Direct-to-consumer (DTC) advertising of prescription drugs has elicited various concerns. One concern is that DTC advertising may add to spending on drugs by consumers, insurers, and the federal government without providing enough benefits to justify that spending; specifically, some observers worry that DTC advertising encourages broader use of certain drugs than their health benefits warrant. Another concern is that DTC advertising for newly approved drugs may lead people to use
drugs whose potential risks were not fully discovered during the drug approval process. Those concerns have spurred recent proposals for a moratorium on advertising brand-name prescription drugs to consumers during the first two years following a drug’s approval by the Food and Drug Administration (FDA). Although such a moratorium would allow more time for safety concerns about a new drug to be revealed, it would entail health risks of its own, because some individuals who would
benefit from a new drug might be unaware of its availability in the absence of consumer advertising..."

Thursday, May 5, 2011

FTC Staff Report Finds 60 Percent Increase in Pharmaceutical Industry Deals That Delay Consumers' Access to Lower-Cost Generic Drugs
"Pharmaceutical companies struck an unprecedented number of deals in Fiscal Year (FY) 2010 in which the manufacturers of branded products paid potential generic rivals and generic companies agreed to defer the introduction of lower-cost medicines for American consumers, according to an overview of industry data released by the staff of the Federal Trade Commission.

The FTC staff report found that the number of these deals skyrocketed more than 60 percent, from 19 in FY 2009 to 31 in FY 2010. Overall, the agreements reached in the latest fiscal year involved 22 different brand-name pharmaceutical products with combined annual U.S. sales of about $9.3 billion..."

Saturday, December 4, 2010

Drugged, Drunk, and Distracted Drivers Put Us All at Risk
"In the past few decades, Americans have come to realize the dangers associated with driving under the influence of alcohol. Thanks to increased awareness and the efforts of concerned groups and
individuals to draw attention to the problem, there has been a decline in the number of people injured or killed as a result of drunk driving. Traffic fatalities in alcohol-impaired-driving crashes decreased nearly 10 percent from 2007 to 2008, according to the National Highway
Traffic Safety Administration (NHTSA).

Alcohol use, however, is only one dangerous behind-the-wheel behavior. Increased attention is now being focused on other types of dangerous driving behavior, such as text messaging, talking on a cell phone, and drugged driving. More than ever, it is time we recognize the dangers of drugged driving and take steps to reduce this threat to our Nation’s health and safety.


Use of any drug that acts on the brain can impair motor skills, reaction time, judgment, and other faculties required for safe driving. Drugged driving is a public health concern because it not only puts the driver at risk; it also endangers the lives of passengers and others sharing
the road..."

Monday, November 1, 2010

Drug Courts: Background, Effectiveness, and Policy Issues for Congress
"Drug courts are specialized court dockets, or portions of judges’ calendars of cases, that generally target nonviolent offenders with substance-abuse problems. These programs provide offenders with intensive court supervision, mandatory drug testing, substance-abuse treatment, and other social services as an alternative to adjudication or incarceration. In this way, drug courts are designed to break the cycle of substance abuse, addiction, and crime by changing the behavior of
substance-abusing offenders. Participation in these programs is voluntary. Eligible defendants
must agree to the program’s requirements and successfully complete the program in exchange for
avoiding incarceration, having their criminal charges reduced or dismissed, or having their
sentences reduced. Drug courts encourage participants’ compliance and impose sanctions on
those who fail to comply with the program’s requirements. Drug courts are widely considered an
important strategy for reducing incarceration, providing drug treatment, and reducing drug use
and recidivism (reoffending) among nonviolent offenders..."

Saturday, October 2, 2010

FDA issues final rule on safety information during clinical trials
"The U.S. Food and Drug Administration today issued a final rule that clarifies what safety information must be reported during clinical trials of investigational drugs and biologics.

“This final rule will expedite FDA’s review of critical safety information and help the agency monitor the safety of investigational drugs and biologics,” said Rachel Behrman, M.D, associate director for medical policy in the FDA’s Center for Drug Evaluation and Research. “These changes will better protect people who are enrolled in clinical trials.”

The new rule requires that certain safety information that previously had not been required to be reported to FDA be reported within 15 days of becoming aware of an occurrence. These reports include:

findings from clinical or epidemiological studies that suggest a significant risk to study participants

serious suspected adverse reactions that occur at a rate higher than expected

serious adverse events from bioavailability studies which determine what percentage and at what rate drug is absorbed by the bloodstream and bioequivalence studies which determine whether a generic drug has the same bioavailability as the brand name drug.."

Tuesday, September 21, 2010

Safe Disposal of Unused Medication
"On September 25, 2010, the Drug Enforcement Administration, U.S. Department of Justice, will coordinate a collaborative effort with state and local law enforcement agencies to remove potentially dangerous controlled substances from our nation’s medicine cabinets. Collection activities will take place from 10:00 a.m. through 2:00 p.m. at sites established throughout the country. To find out more, visit the Take Back page.

Disposal by Flushing of Certain Unused Medicines: What You Should Know
Medicines Recommended for Disposal by Flushing
How to Dispose of Unused Medicines
Medication Disposal: Questions and Answers
Proper Disposal of Prescription Drugs (ONDCP) [PDF - 117KB]"